GENEXPATH
Business purpose.
La recherche, le développement, la production et la commercialisation de produits de diagnostic médicaux, notamment dans le domaine du cancer, de logiciels bio-informatiques et prestations de services associées. Toutes activités de services, commerciales, financières, industrielles et techniques, dans les domaines ci-dessus visés.
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Other research and experimental development on natural sciences and engineering (72.19Z)
- Sector
- Scientific research and development
- Headcount
- 3 to 5 employees
- Created
- 27 Nov 2020
- Share capital
- 401,981.00 EUR
- Registered with the trade register
- 30 Nov 2020
- Financial year end
- 31/12
- Establishments
- 1
Directors
- CLINISCIENCES GROUP President de SAS
Other companies at the same address
6 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
72 / 100 B
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (5.9 years)
- 11.9 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de la fabrication et du commerce des produits à usage pharmaceutique, parapharmaceutique et vétérinaire du 1er juin 1989. Etendue par arrêté du 20 avril 1990 JORF 29 avril 1990
IDCC 1555 · repealed · 1 establishment · declared in July 2026
Legal notices
-
Amendment 31 Aug 2025
- Court :
- Greffe du Tribunal de Commerce de Rouen
- Amendment :
- Modification survenue sur l'administration.
BODACC B n 20250166, annonce n 2250 · Proof of publication (PDF)
-
Filing of accounts 8 Apr 2025
- Court :
- Greffe du Tribunal de Commerce de rouen
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2024
BODACC C n 20250069, annonce n 6667 · Proof of publication (PDF)
-
Amendment 10 Jul 2024
- Court :
- Greffe du Tribunal de Commerce de Rouen
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20240132, annonce n 1808 · Proof of publication (PDF)
-
Filing of accounts 2 Jun 2024
- Court :
- Greffe du Tribunal de Commerce de rouen
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2023
BODACC C n 20240105, annonce n 3713 · Proof of publication (PDF)
-
Filing of accounts 26 May 2023
- Court :
- Greffe du Tribunal de Commerce de rouen
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2022
BODACC C n 20230101, annonce n 3429 · Proof of publication (PDF)
-
Amendment 2 Aug 2022
- Court :
- Greffe du Tribunal de Commerce de Rouen
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20220148, annonce n 2406 · Proof of publication (PDF)
-
Filing of accounts 26 Apr 2022
- Court :
- Greffe du Tribunal de Commerce de rouen
- Type of filing :
- Comptes annuels et rapports
- Closing date :
- 31/12/2021
BODACC C n 20220081, annonce n 3125 · Proof of publication (PDF)
-
Amendment 23 Dec 2021
- Court :
- Greffe du Tribunal de Commerce de Rouen
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20210249, annonce n 3698 · Proof of publication (PDF)
-
Incorporation 2 Dec 2020
- Court :
- GREFFE DU TRIBUNAL DE COMMERCE DE ROUEN
BODACC A n 20200234, annonce n 1652 · Proof of publication (PDF)
Public contracts won
3 current contracts
-
CENTRE HOSPITALIER UNIVERSITAIRE DE CAEN NORMANDIE 66,000 € · 24 Mar 2025
Fourniture de panel NGS pour la caractérisation de lymphomes non hodgkiniens de la société Genexpath pour les besoins du CHU CAEN NORMANDIE
-
CENTRE HOSPITALIER UNIVERSITAIRE DE CAEN NORMANDIE 66,000 € · 24 Mar 2025
Panel NGS pour la classification des lymphomes non hodgkiens
-
CENTRE HOSPITALIER UNIVERSITAIRE GRENOBLE ALPES (HOPITAL NORD) 480,000 € · 28 Feb 2023
Fourniture du test Lymphosign permettant la classification ces lymphomes non hodgkiniens
Source: essential public procurement data (DECP), Open Licence 2.0. Only the current version of each contract is shown.
Filings and accounts
- Formality 27 Aug 2025
Change history
- employee_range 03 → 02 4 Nov 2026
- employee_range 03 → 02 3 Nov 2026
- officer_appointed (empty) → President de SAS 9 Oct 2026
- capital 350742.00 → 271000.00 3 Oct 2026
- capital 401981.00 → 350742.00 3 Oct 2026
- capital 305000.00 → 401981.00 2 Oct 2026
- registered_address (empty) → 113 Avenue des Martyrs de la Résistance 76100 Rouen 1 Oct 2026
- capital (empty) → 305000.00 1 Oct 2026
Frequently asked questions about GENEXPATH
- What is the SIREN number of GENEXPATH?
- The SIREN number of GENEXPATH is 891511933. Its intra-community VAT number is FR13891511933.
- Where is the head office of GENEXPATH?
- Head office address: 113 AV DES MARTYRS DE LA RESISTANCE, 76100 ROUEN.
- When was GENEXPATH founded?
- GENEXPATH was founded on 27 Nov 2020.
- What does GENEXPATH do?
- Its declared main activity is: Other research and experimental development on natural sciences and engineering (NAF code 72.19Z).
- Who runs GENEXPATH?
- The officer listed in the register is CLINISCIENCES GROUP (President de SAS).
- How many employees does GENEXPATH have?
- The declared headcount is 3 to 5 employees. Insee data for 2024.
- Is GENEXPATH subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.